Quoin Pharmaceuticals Ltd. Increase (Decrease) in Interest Payable, Net
Quoin Pharmaceuticals Ltd. (QNRX) reported Increase (Decrease) in Interest Payable, Net of -$311.67 thousand for the 6-month period ending 2022-06-30, per its 6-K filed 2022-08-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInterestPayableNet · last filed 2022-08-18
| Period end | Increase (Decrease) in Interest Payable, Net 6 month | Increase (Decrease) in Interest Payable, Net 12 month |
|---|---|---|
| 2022-06-30 | -$311.67K 6-K · filed 2022-08-18 | |
| 2021-12-31 | $696.80K 20-F · filed 2022-04-14 | |
| 2021-06-30 | $268.11K 6-K · filed 2022-08-18 | |
| 2020-12-31 | $47.04K 20-F · filed 2022-04-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 |